Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 11, 2016

Increased Risk of Bile Duct and Gallbladder Diseases With GLP-1 Analogs in Diabetic Patients

JAMA Internal Medicine

 

Additional Info

JAMA Internal Medicine
Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus
JAMA Intern Med 2016 Aug 01;[EPub Ahead of Print], JL Faillie, OH Yu, H Yin, D Hillaire-Buys, A Barkun, L Azoulay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading